Abstract:Regulatory T (Treg) cells, characterized by expression of the transcription factor forkhead box P3 (Foxp3), maintain immune homeostasis by suppressing self-destructive immune responses1,2,3,4. Foxp3 operates as a late-acting differentiation factor controlling Treg cell homeostasis and function5, whereas the early Treg-cell-lineage commitment is regulated by the Akt kinase and the forkhead box O (Foxo) family of transcription factors6,7,8,9,10. However, whether Foxo proteins act beyond the Treg-cell-commitment stage to control Treg cell homeostasis and function remains largely unexplored. Here we show that Foxo1 is a pivotal regulator of Tregcell function. Treg cells express high amounts of Foxo1 and display reduced T-cell-receptor-induced Akt activation, Foxo1 phosphorylation and Foxo1 nuclear exclusion. Mice with Treg-cell-specific deletion of Foxo1 develop a fatal inflammatory disorder similar in severity to that seen in Foxp3-deficient mice, but without the loss of Treg cells. Genome-wide analysis of Foxo1 binding sites reveals ∼300 Foxo1-bound target genes, including the pro-inflammatory cytokine Ifng, that do not seem to be directly regulated by Foxp3. These findings show that the evolutionarily ancient Akt–Foxo1 signalling module controls a novel genetic program indispensable for Treg cell function. The results of a series of genetic experiments indicate that Foxo1 has a pivotal, Foxp3-independent role controlling regulatory T-cell function. Foxo transcription factors are known to be involved in the control of immune homeostasis at least up to the regulatory T (Treg)-cell commitment stage. This paper reveals a crucial role for Foxo1 in the control of Treg-cell-dependent immune tolerance, independent of Foxo3. The authors propose that Treg cells co-opt the evolutionarily ancient Akt–Foxo1 signalling pathway to control a novel genetic program essential for Treg-cell function. This raises the possibility that manipulating the Akt–Foxo1 signalling pathway might offer a treatment for Treg-cell-associated immunological disorders.

Foxp3 and Toll-like receptor signaling balance Treg cell anabolic metabolism for suppression

Metabolic Choice Tunes Foxp3+ Regulatory T Cell Function.

TGF-β1 Maintains Foxp3 Expression and Inhibits Glycolysis in Natural Regulatory T Cells Via PP2A-mediated Suppression of Mtor Signaling.

Functional reprogramming of regulatory T cells in the absence of Foxp3

TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells

A Novel Role for Triglyceride Metabolism in Foxp3 Expression

Foxp3 Post-translational Modifications and Treg Suppressive Activity

Novel Foxo1-dependent Transcriptional Programs Control Treg Cell Function

Purine metabolic pathway regulates regulatory T cell stability and function

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR

Regulatory T Cells: the Many Faces of Foxp3

Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells

Romance of the three kingdoms: RORgammat allies with HIF1alpha against FoxP3 in regulating T cell metabolism and differentiation

Metabolic profiles of regulatory T cells and their adaptations to the tumor microenvironment: implications for antitumor immunity

Akt and STAT5 mediate naïve human CD4+ T-cell early metabolic response to TCR stimulation

Nemo-like Kinase Drives Foxp3 Stability and is Critical for Maintenance of Immune Tolerance by Regulatory T Cells.

Inhibitory co-receptor Lag3 supports Foxp3+ regulatory T cell function by restraining Myc-dependent metabolic programming

Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression

Special Regulatory T-Cell Review: Foxp3 Biochemistry in Regulatory T Cells - How Diverse Signals Regulate Suppression

Cellular Metabolic Regulation in the Differentiation and Function of Regulatory T Cells